Medical Education

Continuous Medical Education

MphaR Our Services Medical Education

Advancing Medical Expertise Through Continuous Education

MphaR provides a diverse range of Continuous Medical Education (CME) programs designed to support healthcare professionals (HCPs) worldwide. Our goal is to ensure that clinicians have access to the most current, evidence-based knowledge and tools needed to deliver high-quality patient care.

Empowering Physicians in a Rapidly Evolving Digital Era

Technology has transformed the ways we learn, communicate, and access information. In this evolving landscape, CME plays a crucial role in helping medical professionals stay current with scientific and clinical advancements. MphaR is committed to offering flexible education formats that meet the needs of today’s physicians.
  • Digital CME offerings allow HCPs to learn at their own pace through on-demand modules and interactive online content.
  • Unlike traditional in-person training, digital platforms expand access to expertise without limitations of time or location—making high-quality education available to more clinicians than ever before.

Explore Our CME Formats

MphaR offers programs across multiple educational formats—both virtual and in-person—to support different learning styles and clinical needs:

Continuous Medical Education in the Digital Space

MphaR’s digital CME programs are designed to deliver a comprehensive, interactive learning experience that mirrors the depth of in-person training while offering the flexibility of an online format. Our digital courses integrate multiple learning components, advanced engagement tools, and structured educational pathways to support physicians in staying current with rapidly evolving clinical knowledge.

What Our Digital CME Programs Include 

1. Guided Registration & Personalized Access

Participants receive unique login credentials and tailored onboarding instructions, ensuring smooth access to all educational modules, live sessions, and platform features.

2. Live Online Lectures

Our live webinars deliver evidence-based content presented by leading specialists. Sessions often include:

Benefits of NGT: 

  • Real-time polling
  • Interactive Q&A
  • Board-style virtual meeting capabilities
  • Case-based discussions
3. On-Demand Offline Lectures

For learners who cannot attend live sessions, all content is recorded and made available for flexible, self-paced viewing.

Participants gain access to:

  • Full lecture recordings
  • Key takeaways and summaries
  • Attendance analytics (for organizers)
  • Supplementary learning materials
4. Digital Interactive Learning Modules

Beyond lectures, participants receive structured self-learning modules that may include:

  • Articles and curated literature
  • Interactive slide decks
  • Additional reading materials
  • Discussion forums
  • Opportunities to submit questions to faculty

This approach enables learners to deepen understanding at their own pace.

5. Integrated Knowledge Checks

Our digital CME programs incorporate assessments to reinforce learning, such as:

  • Multiple-choice tests
  • Short, case-based quizzes
  • Post-module evaluations

A point-based system can be used to reward progress, track performance, and certify completion.

6. Virtual Workshops

Workshops are designed to stimulate active participation and peer-to-peer learning. They may include:

  • Reading and discussing assigned scientific articles
  • Collaborative problem-solving using virtual boards
  • Group reflections and clinical decision-making exercises

These activities help clinicians translate new evidence into practical applications.

7. Continuous Feedback & Analytics

To maximize the effectiveness of digital learning, the platform provides:

  • Engagement analytics
  • Attendance tracking
  • Polling results
  • Activity-based scoring
  • Insights for both participants and organizers

This ensures transparency and supports ongoing optimization of the educational experience.

Program Scope & Format:

Typical digital CME programs may include:
  • 12-month curriculum
  • 20–30 expert-led lectures
  • 40–50 interactive polls
  • Regular workshops and group activities
  • Access to advanced educational materials throughout the program
These components provide a structured yet flexible pathway for physicians to enhance their expertise.

2.1 Preceptorships & Centers of Excellence (CoE) Programs

Key Features of CoE Programs:

We manage all scientific and operational preparation, including:

Customized program design

Each CoE curriculum is tailored to the scientific needs, training goals, and therapeutic focus of the sponsoring organization.

Intensive format

Typical programs run 1–2 days, enabling concentrated learning that minimizes participants’ time away from clinical duties.

Small-group learning

CoE programs usually host a maximum of 20 HCPs, ensuring an interactive environment with direct access to faculty and institutional experts.

Alignment with major medical congresses

CoE visits are often organized around leading conferences such as ASCO, ESMO, EHA, and ASH, enabling participants to benefit from both congress content and on-site institutional experience.

Strategic planning

To ensure smooth coordination with host centers, planning begins at least 7 months in advance.

Program Components

Educational Activities

CoE programs typically combine:

  • Institutional introductions and facility tours
  • Expert-led clinical lectures
  • Case-based discussions
  • Departmental visits and observation of workflows
  • Exposure to multidisciplinary team practices
  • Review of real-world treatment pathways and protocols

This structure allows clinicians to gain practical insights into global standards of care.

MphaR Services Across the Entire CoE Journey

1. Preparation Phase

MphaR provides comprehensive support throughout the planning and development process:

  • Coordination and contracting with host institutions and faculty
  • Agenda design aligned with learning objectives
  • Supervision of all educational materials and presentations
  • Communication with institutions, participants, and company teams
  • Development of digital and print program materials, including graphic design
  • Securing compliance approvals

This ensures that every CoE program is scientifically robust, logistically sound, and aligned with compliance requirements.

2. On-Site Support During the Event

To guarantee a smooth and professional experience for all participants, MphaR manages:

  • On-site staff support
  • Accommodation arrangements
  • Meal coordination
  • Travel and transfer logistics
  • Conference room and venue management
  • Audiovisual setup and technical readiness

Participants can focus entirely on learning while MphaR manages all operational details.

3. Post-Event Follow-up

After the program, MphaR ensures seamless closure and documentation:

  • Issuing attendance certificates
  • Sending personalized “thank you” letters
  • Distributing educational materials (subject to institutional approval)
  • Preparing complete event and attendee feedback reports

This reinforces learning and provides valuable insights for future program planning.

4.Compliance Oversight

MphaR works closely with company compliance teams to ensure that every aspect of the CoE program meets applicable industry and institutional regulations:

  • Liaison with compliance representatives
  • Review and approval of all materials
  • Support in ensuring adherence to legal and regulatory requirements

Our Institutional Network

MphaR collaborates with a wide range of leading global Centers of Excellence across the US, Canada, and Europe. Partners include:

These long-standing partnerships allow us to deliver high-quality, scientifically rigorous CoE experiences across multiple specialties.

2.2 Accredited Face-to-Face Courses

Accredited events are structured, high-quality educational programs that combine scientific rigor with interactive learning to ensure healthcare professionals gain clinically relevant knowledge and can effectively apply it in real-world practice. These programs are developed in collaboration with respected academic and medical institutions and follow national and international accreditation standards.

MphaR organizes accredited courses such as the CLL-CARE Schools, Hema-Care Schools, Breast Cancer Schools, and other disease-focused educational programs that provide participants with recognized CME credits and advanced, specialty-specific learning experiences.

1. What Defines an Accredited Event

Accredited programs prioritize active learning through:
  • Case-based discussions
  • Real-world clinical scenarios
  • Digital tools and interactive platforms
  • Peer-to-peer conversations
  • Faculty-led Q&A and problem-solving
These approaches enhance knowledge retention and promote the translation of insights into day-to-day clinical decision-making.

2. Scientifically Robust Curriculum

All accredited events are designed around:
  • Current clinical evidence
  • Updated treatment guidelines
  • Evolving therapeutic strategies
  • Emerging research and innovations
The curriculum is structured to provide balanced, unbiased, and actionable education.

Participant Benefits

All accredited events are designed around:

We manage all scientific and operational preparation, including:

Gain valuable insights into real-world clinical practice:

Through faculty-led discussions, multidisciplinary perspectives, and practical examples from leading institutions.

Navigate the expanding evidence base and emerging treatments

Preparing them to integrate new scientific advances into clinical decision-making.

Strengthen their understanding of disease burden and evolving treatment landscapes

Including diagnostic challenges, patient pathways, modern therapeutics, and best-practice management strategies.

Earn recognized CME credits

Supporting their ongoing professional development and meeting national licensure requirements.

Why MphaR Accredited Events Stand Out

Developed in collaboration with leading centers of excellence and top-tier academic institutions

Scientifically independent, unbiased, and compliant

Tailored to specific therapeutic areas, including oncology, hematology, and chronic disease management

Available in multiple formats (face-to-face, hybrid, and digital)

Commitment to Quality and Impact

All MphaR accredited courses are developed with the highest commitment to scientific independence, educational integrity, and clinical relevance. Through a combination of expert faculty, rigorous content development, and interactive learning environments, our programs empower healthcare professionals to deliver better, evidence-based care to their patients.

2.3 Medical Congresses & Symposia

MphaR supports the full development and delivery of symposia and medical congress activities, ensuring that every scientific event is expertly organized, compliant, and impactful. Our services cover all stages of planning and execution, enabling companies and medical teams to focus entirely on delivering high-value scientific content while we manage the operational, communication, and compliance aspects.
Whether integrated into major international congresses or organized as standalone scientific sessions, our symposia services ensure a seamless experience for speakers, participants, and organizers.

Our Expertise Across Every Stage of the Event Preparation

1. Preparation

MphaR provides comprehensive support throughout the planning and development process:
  • Coordination and contracting with host institutions and faculty
  • Agenda design aligned with learning objectives
  • Supervision of all educational materials and presentations
  • Communication with institutions, participants, and company teams
  • Development of digital and print program materials, including graphic design
  • Securing compliance approvals

This ensures that every CoE program is scientifically robust, logistically sound, and aligned with compliance requirements.

2. During the Event

MphaR provides on-site support to guarantee smooth execution and an optimal experience for all participants:
  • On-site MphaR coordination and logistics management
  • Audio/visual setup and technical support
  • Venue and conference room management

This ensures that speakers can focus on presenting, attendees can learn without distraction, and the event runs flawlessly.

3. After the Event

Following the symposium or congress activity, we ensure complete, efficient follow-up:
  • Issuance of attendance certificates
  • Distribution of “thank you” communications to participants and speakers
  • Preparation of a full post-event report, including attendance metrics and insights

These deliverables help you measure impact and maintain strong relationships with participants.

4. Compliance Support

Compliance is integrated into every step of the process:
  • Collaboration with your company’s compliance team
  • Ensuring adherence to all applicable rules and congress requirements
  • Support in obtaining compliance approval for all event materials

This ensures transparency, regulatory alignment, and scientific integrity.

Why Partner with MphaR for Symposia?

End-to-end event management

Strong experience working with major international congresses

Professional materials, design, and scientific content support

Seamless coordination with expert speakers and organizers

Full compliance oversight and documentation

MphaR ensures that your presence at medical congresses is professional, impactful, and aligned with the highest educational and scientific standards.
MphaR Virtual Platform
May – December 2025

International Infectious Disease Education

This educational programme for physicians (mainly GPs/PCPs) and nurses on RSV, hMPV, and Flu, has been designed to increase their awareness and improve knowledge of these viruses.

The aim of the overall programme is to create a dynamic and stimulating learning environment for HCPs, enabling them to further their knowledge, refine their existing skills, and enhance professional growth

MphaR Virtual Platform
November 18th, 2025

CLL Care Webinar “Navigating Targeted Therapy in CLL: Best Practices in Treatment Sequencing” (Speaker: Othman Al-Sawaf)

  • To review current targeted therapies for CLL, including BTK and BCL2 inhibitors, anti-CD20 agents, and combination strategies
  • To explore resistance mechanisms and treatment sequencing after failure or intolerance, with practical guidance for BTKi- and/or BCL2i-exposed patients
  • To highlight emerging therapies and future directions, such as non-covalent BTKis, CAR-T, bispecific antibodies, and novel agents
Online / MphaR Virtual Platform
September 17th, 2025

CLL Care Webinar “Finite Therapy in CLL: Practical Guidance on Selection and Clinical Applications” (Speaker: Stephan Stilgenbauer)

  • To understand the rationale and benefits of finite therapy in CLL
  • To review key finite therapy regimens and their clinical application
  • To explore the role of MRD and future directions in finite treatment
  • To provide practical guidance on patient selection and management of finite therapy
Madrid, Spain
June 9th - 10th, 2025

inSPOT Center of Excellence

  • The program aimed to enhance rheumatologists’ knowledge of recent advancements and emerging trends in the management of Systemic Lupus Erythematosus (SLE)
  • Through expert-led, peer-to-peer engagement, participants explored evidence-based diagnostic and therapeutic strategies aligned with international guidelines and best practices from a leading-edge clinical centre
May 27th-28th, 2025

INSPIRE-BC (Center of Excellence on Breast Cancer)

Update and mentor attendees on advances in breast cancer (BC) management by peer-to-peer interaction with experts who treat patients according to international guidelines and best standards of care in a leading-edge cancer center

Pavia, Italy
May 14th - 15th, 2025

ATTRv Amyloidosis Preceptorship

HCPs to familiarize themselves with the diagnostic methodologies, share the multidisciplinary approach and discuss the still controversial elements in the classification and management of these complex pathologies in ATTRv Amyloidosis

MphaR Virtual Platform
May 14th, 2025

CLL Care Webinar “Deeper Exploration of Cardiovascular Complications in CLL: Insights and Management Strategies” (Speakres: Maria Sol Andres, Clemens-Martin Wendtner)

  • To understand the mechanisms behind cardiovascular complications associated with CLL
  • To discuss risk factors related to both the disease and its treatments, and patient profile
  • To explore the latest insights and strategies for managing cardiovascular complications to improve patient outcomes
MphaR Virtual Platform
April – May 2025

HER2 Tumour Agnostic Virtual Masterclasses

  • Update and educate attendees on the evolution of tumour agnostic indications (non-breast/non-gastric). Learn about HER2 biology, its clinical value and expression on different tumour types
  • Understand the role of the pathologists in diagnostic pathways and explore different tumours journeys
  • Improve pathologists’ capabilities for scoring HER2 in tumour agnostic (non-breast/non-gastric)
MphaR Virtual Platform
March 12th, 2025

CLL Care Webinar “Navigating CLL Resistance: BTK and Bcl2 mutations and treatment strategies” (Speaker: Philip Thompson)

  • To understand resistance in CLL treatment
  • To discuss treatment strategies for when resistance emerges in therapy
  • To explore new treatment strategies on the horizon
Madrid, Spain + MphaR Virtual Platform
March 3rd, 2025

Breast Cancer Academy: HR+/ HER2- Metastatic Breast Cancer

  • Update on the current understanding of the biology of breast cancer (HR+/HER2−, advanced) and the current treatment landscape and strategies
  • Discuss the management of adverse events in clinical practice
  • Introduce and discuss the psychological aspects of supportive care for patients with metastatic breast cancer
  • Raise awareness of current biomarker testing and establish the role of biomarker testing in treatment strategies

 

Brno, Czech Republic
February 20th, 2025

Breast Cancer School 2025

  • Provision of the latest information on the biology of breast cancer (HR+/HER2−, advanced carcinoma) and current treatment approaches
  • Raising awareness of current biomarker testing and defining the role of biomarker testing in treatment strategies
  • Discussion of the management of adverse effects in clinical practice
  • Introduction to rehabilitation approaches for patients with metastatic breast cancer

 

F2F, Madrid, Spain / Online - MphaR Virtual Platform
February 14th, 2025

B-Cell Care School “Practical Aspects of B-Cell Malignancy Management: Update for Hematologists”

  • Update hematologists on future clinical perspectives and cutting-edge approaches in the diagnosis and treatment of B-cell malignancies, including the role of immunochemotherapies and the different generations of targeted therapies and CAR-T cells
  • Enhance clinical capabilities through the discussion of complex cases of B-cell malignancies (such as treatment resistance and relapses) and the psychological aspects to consider in interactions between the clinician and the caregiver
Online / MphaR Virtual Platform
January 21st, 2025

CLL Care Webinar “ASH 2024 CLL Highlights” (Speaker: Antonio Cuneo)

  • Highlight the latest advancements in frontline CLL therapies, including BTKi and BCL2i combinations and fixed-duration treatments
  • Explore the role of MRD-guided treatment strategies in CLL, focusing on early response indicators and treatment adjustments
  • Discuss the significance of predictive markers in CLL prognosis and explore emerging therapies for relapsed/refractory CLL, along with the future direction of treatment
F2F, Barcelona, Spain
January 1st, 2025

Breast Cancer Academy: HR+/ HER2- Metastatic Breast Cancer

  • Update on the current understanding of the biology of breast cancer (HR+/HER2−, advanced) and the current treatment landscape and strategies
  • Discuss the management of adverse events in clinical practice
  • Introduce and discuss the psychological aspects of supportive care for patients with metastatic breast cancer
  • Raise awareness of current biomarker testing and establish the role of biomarker testing in treatment strategies
Online
September 17th 2025

CLL-CARE Webinar 9. Finite Therapy in CLL: Practical Guidance on Selection and Clinical Applications

In this webinar, Prof. Stephan Stilgenbauer will explore finite therapy in CLL, providing practical guidance on treatment selection and clinical applications. He will highlight the role of targeted therapies versus chemotherapy, strategies for achieving durable disease control, and key considerations when choosing between continuous and fixed-duration approaches.

Online
May 12, 2025

CLL-CARE Webinar 7. Navigating CLL Resistance: BTK and Bcl2 mutations and treatment strategies

In this webinar, Dr. Philip Thompson covers the mechanisms of action of current CLL therapies, methods for assessing resistance, treatment intolerance, and strategies for managing resistance. He discusses resistance to BTK and BCL2 inhibitors and explores new treatment strategies, including novel targeted therapies, antibody therapies, and CAR-T therapies for refractory CLL.

Online
May 14th 2025

CLL-CARE Webinar 8. A Deeper Exploration of Cardiovascular Complications in CLL: Insights and Management Strategies

In this webinar, Prof. Clemens M. Wendtner will cover the topic of cardiovascular complications associated with CLL, focusing on underlying mechanisms, risk factors, and the latest insights into managing these challenges to optimize patient care

Madrid, Spain & Online
March 3rd, 2025

Breast Cancer School

This is an educational program developed for oncologists, focusing on the treatment of HR+/HER2- metastatic breast cancer, biomarkers, and new treatment strategies. Breast Cancer School’s program is accredited by the Illustrious official college of physicians of Madrid and led by Dr. Javier Cortés Castán alongside Dr. Antonio Llombart Cussac, Dr. Gemma Viñas Vilaró, Dr. María Fernandez Abad, and psychologist Fátima Castaño Ferrero, experts in breast cancer treatment who will share their clinical expertise and understanding of patient care.

Brno, Czech Republich & Online
February 20th, 2025

Breast Cancer School

This is an educational program developed for oncologists, focusing on the treatment of HR+/HER2- metastatic breast cancer, biomarkers, and new treatment strategies. The program of this educational event is led by MUDr. Katarína Petráková, Ph.D., Prof. François Clément Bidard (France), and Prof. Giuseppe Curigliano (Italy) – leading experts in breast cancer treatment who will share their clinical experience and insights in patient care.

Madrid, Spain & Online
February 14th 2025

Hematology School

Hematology Academy is an educational program developed for hematologists, focused on the cutting-edge diagnosis and treatment of B-cell malignancies, including immunochemotherapies, targeted therapies, and CAR-T cell treatments.

Online
January 25th, 2025

CLL-CARE Webinar 6. ASH 2024 Highlights

In this webinar, Prof. Antonio Cuneo focused on exploring emerging therapies in CLL, discussing the clinical trials presented at ASH 2024, and considering the implications of minimal residual disease on patient quality of life.

Barcelona, Spain & Online
January 18th, 2025

Breast Cancer School

This is an educational program developed for oncologists, focusing on the treatment of HR+/HER2- metastatic breast cancer, biomarkers, and new treatment strategies. Breast Cancer School’s program is accredited by the Illustrious official college of physicians of Madrid and led by Dr. Javier Cortés Castán alongside Dr. Antonio Llombart Cussac, Dr. Gemma Viñas Vilaró, Dr. María Fernandez Abad, and psychologist Fátima Castaño Ferrero, experts in breast cancer treatment who will share their clinical expertise and understanding of patient care.

Online
Online December 2023 – May 2024

Comprehensive Advances in patients caRE

This project educates and guides participants on current and future aspects of Chronic Lymphocytic Leukaemia (CLL) via online webinars. Topics include challenges in treatment, BTK inhibitors’ role in clinical decisions, and future disease management directions.

Online
November 29th 2024

CLL-CARE Webinar 5. Management of high-risk and Relapsed/Refractory CLL​

This interactive online webinar is specifically designed to focus on the evolving landscape of R/R CLL treatment, discussion of clinical guidelines, treatment strategies, and specific patient considerations

Pavia, Italy
October, 2024

ATTRv Amyloidosis Center of Excellence​

This educational event is aimed at HCPs to familiarize themselves with the diagnostic methodologies, share the multidisciplinary approach and discuss the still controversial elements in the classification and management of these complex pathologies in ATTRv Amyloidosis

Online
July 29th, 2024

CLL-CARE Webinar 4. Richter syndrome: Risk factors and molecular insights

This interactive online webinar is specifically designed to focus on critical risk factors and molecular insights related to Richter Transformation, focusing on their application in clinical settings.

Boston,USA
May 28th and 29th, 2024

iNBRACE INternational BReAst Cancer Patient Experience optimization​​

This event aims to update and mentor attendees on advances in breast cancer (BC) management by peer-to-peer interaction with experts who treat patients according to international guidelines and best standards of care in a leading-edge cancer center.

Online
April 30th, 2024

CLL-CARE Webinar 3. The CLL Patient Experience​

This interactive online webinar is specifically designed to focus on patients’ perspective on CLL management and real-life factors to improve patients’ outcomes.

Online
April-December, 2024

Nutrition in CKD

This educational programme is aimed at nurses, nephrologists, physicians, and other healthcare professionals.

Online
March – December, 2024

International Nurse Education. From A to Z

These educational programmes are designed for exceptional nurses across the globe looking to enhance their knowledge, skills, and professional development in respiratory virus infections.

Online
March 20th, 2024

CLL-CARE Webinar 2. Challenges and Future of CLL Treatment

This interactive online webinar is specifically designed to focus on associated challenges to CLL treatment, clinical decision-making on BTK inhibitors, and future directions of disease management.

Online
February 8th, 2024

CLL-CARE Webinar 1. The evolving BTK inhibitors landscape

This interactive online webinar is specifically designed to focus on current practices, second- and third-generation agents, CLL patient selection, and practical considerations.

January- June, 2023

Online Educational Program CLL Masterclass with MDACC specialists

The CLL Masterclass Educational Program with MD Anderson Cancer canter specialists (CMCEP). You will have access to the recording of the lectures from top-level experts and listen to discussions about best practices and difficult cases on the latest advancing therapy in CLL

March 13th, from 5:30 to 7:00pm 2023

Current and Future Testing Strategies to Optimize Disease Management

This seminar provides an overview of the benefits and challenges of testing for various molecular biomarkers in breast cancer from the perspective of the pathologist

June 26th & 27th, 2023

Educational Liver Cancer Program

This project aims to update Medical Oncologists on advances in Liver Cancer Management by peer-to-peer interaction with experts who treat patients according to international guidelines and basic standards of care.

October 25th & 26th, 2023

Hepatocellular Carcinoma Educational Program

This project aims to update and mentor attendees on advances in HCC management through peer-to-peer interaction with experts who treat patients according to international guidelines and basic standards of care.

San Diego, California
December 10th, 2023

The present and future of CLL: optimizing BTK inhibitor selection to improve patient outcomes

This project aims to educate hematologists globally about the latest CLL management developments, facilitating in-depth discussions on CLL treatment’s evolving landscape for better patient care and outcomes.

Madrid, Spain
November 15th & 16th, 2023

Optimizing the Best Strategies in the Management of Patients with Breast Cancer

This program aims to update participants on advances in the diagnosis and management of breast cancer through scientific exchange discussions with experts who treat patients according to international healthcare guidelines.

×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure